Karyopharm Therapeutics Q3 Results Preview: EPS Estimate at $(0.95)
Karyopharm Therapeutics is scheduled to report Q3'26 results on October 29. EPS is estimated at $(0.95); the release time is unspecified.
KPTI (Karyopharm Therapeutics Inc.) is set to announce its Q3'26 results on October 29, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q3'26, revenue estimate is 33.54 million USD with EPS (earnings per share) anticipated at (0.95) USD. Learn more det…